Page 17 - கோர் ஒன்று ஆய்வகங்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Core One Labs Inc.: Core One Labs Highlights Key Points from International Investor Call Core One the Company ) is pleased with the tremendous turnout on the International Investors Call held earlier today. Core One s Chairman, Dr. Robert E.W. Hancock and Chief Executive Officer, Joel Shacker provided participants an update on the Company s current Intellectual Property and patent application process, cost to produce psilocybin, and the commercial viability. Highlights Intellectual Property and Patent Process Dr. Hancock announced that the Company has assembled the necessary data for its research and development program on biosynthetic psilocybin production systems in order to commence the process of preparing and filing its first patent application with the United States Patent and Trademark Office. The initial filing is the first in a series of upcoming patent filings aimed at protecting valuable intellectual property that underpins the proprietary fermentative production

United statesBritish columbiaRobertew hancockJoel shackerCore one labCore one the companyInternational investor callTrademark officeCore one labs incDrug administration good manufacturing practiceCanadian securities exchangeHealth canadaCore one labsChief executive officerIntellectual propertyUnited states patent